Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 308, Issue 7, 2015, Pages G634-G642

  Zhang, Linda S ^a   Xu, Min ^a   Yang, Qing ^a   Ryan, Robert O ^b   Howles, Philip ^a   Tso, Patrick ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Absorption; Intestine

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B; CHYLOMICRON; OLEIC ACID; APOA5 PROTEIN, MOUSE; APOLIPOPROTEIN; CHOLESTEROL; TRIOLEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FAT INTAKE; FISTULA; HYPERTRIGLYCERIDEMIA; INTESTINE ABSORPTION; INTESTINE MUCOSA; LIPID ABSORPTION; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN DEFICIENCY; LYMPH FISTULA; LYMPH VESSEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DUODENUM; GENETICS; KNOCKOUT MOUSE; LYMPH; LYMPHATIC SYSTEM; LYMPHATIC SYSTEM DISEASE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; TIME; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; APOLIPOPROTEINS; CHOLESTEROL; CHYLOMICRONS; DISEASE MODELS, ANIMAL; DUODENUM; FISTULA; INTESTINAL ABSORPTION; LYMPH; LYMPHATIC DISEASES; LYMPHATIC SYSTEM; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; POSTPRANDIAL PERIOD; TIME FACTORS; TRIOLEIN; UP-REGULATION;

EID: 84929626879     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00339.2014     Document Type: Article

References (76)

1. Aberdeen V, Shepherd PA, Simmonds WJ. Concurrent measurement, in unanaesthetized rats, of intestinal transport and fat absorption from the lumen. Exp Physiol 45: 265–274, 1960.
2. Albers JJ, Kennedy H, Marcovina SM. Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data. J Lipid Res 37: 192–196, 1996.
3. Beckstead JA, Oda MN, Martin DD, Forte TM, Bielicki JK, Berger T, Luty R, Kay CM, Ryan RO. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry 42: 9416–9423, 2003.
4. Beigneux AP, Davies B, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, Blaner WS, Ding ZM, Melford K, Wongsiriroj N, Shu X, de Sauvage F, Ryan RO, Fong LG, Bensadoun A, Young SG. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 5: 279–291, 2007.
5. Bennett S, Simmonds WJ. Absorptive capacity and intestinal motility in unanaesthetized rats during intraduodenal infusion of fat. Exp Physiol 47: 32–38, 1961.
6. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771–1775, 2000.
7. Bergstedt SE, Hayashi H, Kritchevsky D, Tso P. A comparison of absorption of glycerol tristearate and glycerol trioleate by rat small intestine. Am J Physiol Gastrointest Liver Physiol 259: G386–G393, 1990.
8. Blade AM, Fabritius MA, Hou L, Weinberg RB, Shelness GS. Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion. J Lipid Res 52: 237–244, 2011.
9. Bollman JL, Cain JC, Grindlay JH. Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat. J Lab Clin Med 33: 1349–1352, 1948.
10. Borgstrom B. On the mechanism of the intestinal fat absorption. The effect of bile diversion on fat absorption in the rat. Acta Physiol Scand 28: 278–286, 1953.
11. Calandra S, Oliva CP, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 17: 122–127, 2006.
12. Chen YD, Swami S, Skowronski S, Coulston A, Reaven GM. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76: 172–177, 1993.
13. Dichlberger A, Cogburn LA, Nimpf J, Schneider WJ. Avian apolipoprotein A-V binds to LDL receptor gene family members. J Lipid Res 48: 1451–1456, 2007.
14. Evans D, Buchwald A, Beil FU. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 81: 645–654, 2003.
15. Fruchart-Najib J, Bauge E, Loredan-Stefan N, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 319: 397–404, 2004.
16. Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb 16: 145–154, 2009.
17. Gao X, Forte TM, Ryan RO. Influence of apolipoprotein A-V on hepatocyte lipid droplet formation. Biochem Biophys Res Commun 427: 361–365, 2012.
18. Gonzales JC, Gordts PL, Foley EM, Esko JD. Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. J Clin Invest 123: 2742–2751, 2013.
19. Groenendijk M, Cantor RM, de Bruin TW, Dallinga-Thie GM. The apoAI-CIII-AIV gene cluster. Atherosclerosis 157: 1–11, 2001.
20. Grosskopf I, Baroukh N, Lee SJ, Kamari Y, Harats D, Rubin EM, Pennacchio LA, Cooper AD. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride- rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol 25: 2445–2447, 2005.
21. Havasi V, Szolnoki Z, Talian G, Bene J, Komlosi K, Maasz A, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bodor A, Melegh B. Apolipoprotein A5 Gene Promoter Region T-1131C Polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 29: 177–183, 2006.
22. Hayashi H, Nutting DF, Fujimoto K, Cardelli JA, Black B, Tso P. Transport of lipid and apolipoprotein A-I and A-IV in intestinal lymph of the rat. J Lipid Res 31: 1613–1625, 1990.
23. Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A, Hattori H, Smelt AH, van Dijk KW. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Atherosclerosis 193: 129–134, 2007.
24. Hodis HN. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99: 2852–2854, 1999.
25. Hyun SA, Vahouny GV, Treadwell CR. Portal absorption of fatty acids in lymph- and portal vein-cannulated rats. Biochim Biophys Acta 137: 296–305, 1967.
26. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii Tsuji M, Ide H, Miller IP, Miller NE, Hattori H. A sandwich enzymelinked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 46: 2015–2022, 2005.
27. Jang Y, Kim JY, Kim OY, Lee JE, Cho H, Ordovas JM, Lee JH. The -1131TC polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations, and oxidative stress in nonobese Korean men. Am J Clin Nutr 80: 832–840, 2004.
28. Kalogeris TJ, Fukagawa K, Tso P. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J Lipid Res 35: 1141–1151, 1994.
29. Kao J, Wen H, Chien K, Hsu H, Li S. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12: 2533–2539, 2003.
30. Karpe F, Steiner G, Uffelman K, Olivercrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106: 83–97, 1994.
31. Kohan AB, Howles PN, Tso P. Methods for studying rodent intestinal lipoprotein production and metabolism. Curr Pro Mouse Biol 2: 219–230, 2012.
32. Lai C, Tai E, Tan CE, Cutter J, Chew SK, Zhu Y, Adiconis X, Ordovas JM. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44: 2365–2373, 2003.
33. Lewis GF, O’Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS. Fasting hypertriglyceridemia in noninsulindependent diabetes mellitus is an important predictor of postprandial lipid and lipoproteins abnormalities. J Clin Endocrinol Metab 72: 934–944, 1991.
34. Lopez-Miranda L, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences in postprandial lipid metabolism. Brit J Nutr 98: 458–473, 2007.
35. Mahley RW, Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lip Res 25: 1277–1294, 1984.
36. Mamo JC, Proctor SD, Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanisms from plasma. Atherosclerosis 141: S63–S69, 1998.
37. McDonald GB, Saunders DR, Weidman M, Fisher L. Portal venous transport of long-chain fatty acids absorbed from rat intestine. Am J Phyiol Gastrointest Liver Physiol 239: G141–G150, 1980.
38. Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280: 21553–21560, 2005.
39. Moreno R, Perez-Jimenez F, Marin C, Moreno JA, Gomez P, Bellido C, Perez-Martinez P, Jimenez-Gomez Y, Fuentes FJ, Lopez-Miranda J. A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism. Atherosclerosis 189: 163–168, 2006.
40. Moreno-Luna R, Perez-Jimenez F, Marin C, Perez-Martinez P, Gomez P, Jimenez-Gomez Y, Delgado-Lista J, Moreno JA, Tanaka T, Ordovas JM, Lopez-Miranda J. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy caucasian population. J Clin Endocrinol Metab 92: 2280–2285, 2007.
41. Murphy DJ. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog Lipid Res 40: 325–438, 2001.
42. Nabika T, Nasreen S, Kobayashi S, Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 165: 201–204, 2002.
43. Nakamura T, Kugiyama K. Triglycerides and remnant particles as risk factors for coronary artery disease. Curr Atheroscler Rep 8: 107–110, 2006.
44. Nauli AM, Nassir F, Zheng S, Yang Q, Lo CM, Vonlehmden SB, Lee D, Jandacek RJ, Abumrad NA, Tso P. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 131: 1197–1207, 2006.
45. Nilsson SK, Christensen S, Raarup MK, Ryan RO, Nielson MS, Olivecrona G. Endocytosis of apolipoprotein AV by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem 283: 25920–25927, 2008.
46. Nilsson SK, Lookene A, Beckstead JA, Gliemann G, Ryan RO, Olivecrona G. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 46: 3896–3904, 2007.
47. O’Brien PJ, Alborn WE, Sloan JH, Ulmer M, Boodhoo A, Knierman MD, Schultze AE, Konrad RJ. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 51: 351–359, 2005.
48. Pal S, Semorine K, Watts GF, Mamo J. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med 41: 792–795, 2003.
49. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169–173, 2001.
50. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031–3038, 2002.
51. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88: 2762–2770, 1993.
52. Plosch T, Kosters A, Groen AK, Kuipers F. The ABC of hepatic and intestinal cholesterol transport. Hepatology 170: 465–482, 2005.
53. Proctor SD, Mamo JC. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 7: 239–245, 1996.
54. Proctor SD, Mamo JC. Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscl Thromb Vasc Biol 23: 1595–1600, 2003.
55. Qu S, Perdomo G, Su D, D’Souza FM, Shachter NS, Dong HH. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice. J Lipid Res 48: 1476–1487, 2007.
56. Redgrave TG. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest 49: 465–471, 1970.
57. Ribalta J, Figuera L, Fernandez-Ballart J, Vilella E, Cabezas MC, Masana L, Joven J. Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 48: 1597–1600, 2002.
58. Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW. ApoAV reduces plasma triglycerides by inhibiting very low density lipoproteintriglyceride (VLDL-TG) production and stimulating lipoprotein lipasemediated VLDL-TG hydrolysis. J Bio Chem 279: 27941–27947, 2004.
59. Schaap FG, Nierman MC, Berbee JF, Hattori H, Talmud PJ, Vaessen SF, Rensen PC, Chamuleau RA, Kuivenhoven JA, Groen AK. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia. J Lipid Res 47: 2333–2339, 2006.
60. Sewell RB, Mao SJ, Kawamoto T, LaRusso NF. Apolipoproteins of high, low, and very low density lipoproteins in human bile. J Lipid Res 24: 391–401, 1983.
61. Sharma V, Beckstead JA, Simonsen JB, Nelbach L, Watson G, Forte TM, Ryan RO. Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice. Arterioscler Thromb Vasc Biol 33: 474–480, 2013.
62. Shu X, Chan J, Ryan RO, Forte TM. ApoA-V association with intracellular lipid droplets. J Lipid Res 48: 1445–1450, 2007.
63. Shu X, Ryan RO, Forte TM. Intracellular lipid droplets targeting by apolipoprotein A-V requires the carboxyl-terminal segment. J Lipid Res 49: 1670–1676, 2008.
64. Shu X, Nelbach L, Ryan RO, Forte TM. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation. Biochim Biophys Acta 1801: 605–608, 2010.
65. Talmud PJ, Cooper JA, Hattori H, Miller IP, Miller GJ, Humphries SE. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia 49: 2337–2340, 2006.
66. Tomkin GH, Owens D. The chylomicron: relationship to atherosclerosis. Int J Vasc Med 2012: 784536, 2012.
67. Tso P, Barrowman JA, Granger DN. Importance of interstitial matrix hydration in intestinal chylomicron transport. Am J Physiol Gastrointest Liver Physiol 250: G497–G500, 1986.
68. Tso P, Pitts V, Granger DN. Role of lymph flow in intestinal chylomicron transport. Am J Physiol Gastrointest Liver Physiol 249: G21–G28, 1985.
69. Van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276: 44512–44520, 2001.
70. Van der Vliet HN, Schaap FG, Levels JH, Ottenhoff R, Looije N, Wesseling JG, Groen AK, Chamuleau RA. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295: 1156–1159, 2002.
71. Watts GF, Mamo JC, Redgrave TG. Postprandial dyslipidaemia in a nutshell: food for thought. Aust N Z J Med 28: 816–823, 1998.
72. Weinberg RB, Cook VR, Beckstead JA, Martin DD, Gallagher JW, Shelness GS, Ryan RO. Structure and Interfacial Properties of Human Apolipoprotein A-V. J Biol Chem 278: 34438–34444, 2003.
73. Weinberg RB, Gallagher JW, Fabritius MA, Shelness GS. ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceriderich lipoproteins. J Lip Res 53: 736–743.
74. White D, Bennett A, Billett M, Salter AM. The assembly of triacylglycerol- rich lipoproteins: an essential role for the microsomal triacylcerol transfer protein. Br J Nutr 80: 219–229, 1998.
75. Wu AL, Clark SB, Holt PR. Transmucosal triglyceride transport rates in proximal and distal rat intestine in vivo. J Lip Res 16: 251–257, 1975.
76. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 41: 153–158, 1995.